Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mild cognitive impairment.

Howard H Feldman1, Claudia Jacova

  • 1Division of Neurology, Dept. of Medicine, Clinic for Alzheimer Disease and Related Disorders, University of British Columbia, S192-2211 Wesbrook Mall, Vancouver, British Columbia, Canada V6T 2B5. hfeldman@interchange.ubc.ca

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|August 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"We feel like we don't matter": the work experience of caring for long-term care residents with suspected trauma-related responsive behaviors.

BMC health services research·2026
Same author

Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer's disease.

Neurodegenerative disease management·2026
Same author

Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials.

Lancet (London, England)·2026
Same author

Validation of a novel cognitive-functional outcome measure optimized for early Alzheimer's Disease: Evidence from the VIVA-MIND trial.

The journal of prevention of Alzheimer's disease·2026
Same author

A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA.

The Lancet. Neurology·2026
Same author

Relationships between fine memory discrimination and tau burden in two independent cohorts of older adults.

Neuropsychologia·2026
Same journal

Reconsidering Outcome Metrics and Clinical Meaning in Late-Life Anxiety Treatment.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same journal

Response to "Comment on 'A Systematic Review and Meta-Analysis of Diagnostic Remission, Treatment Response, Attrition and Relapse Following Cognitive Behavior Therapy (CBT), Other Psychological Therapies and Pharmacological Treatments for Anxiety Disorders in Older Adults'".

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same journal

Benefit and Uptake: A Mixed Methods Study Exploring Older Adults' Experiences With a Psychoeducational and Exercise Training Maintenance Intervention.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same journal

Cannabinoid Treatments for Agitation in Alzheimer's Disease.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same journal

Response to "Reconsidering Outcome Metrics and Clinical Meaning in Late-Life Anxiety Treatment".

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same journal

Comment on "A Systematic Review and Meta-Analysis of Diagnostic Remission, Treatment Response, Attrition and Relapse Following Cognitive Behavior Therapy (CBT), Other Psychological Therapies and Pharmacological Treatments for Anxiety Disorders in Older Adults".

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
See all related articles

Mild cognitive impairment (MCI) is a condition below dementia levels, increasing with age. Early assessment and management are key for patients at higher risk of dementia progression.

Area of Science:

  • Neurology
  • Gerontology
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) represents a transitional stage between normal aging and dementia.
  • Its prevalence rises with age in aging populations, posing a significant public health challenge.
  • Understanding MCI subtypes like amnestic MCI (MCIa) is crucial for accurate diagnosis.

Purpose of the Study:

  • To review the current understanding and diagnostic approaches to MCI.
  • To highlight the heterogeneity and prognostic implications of MCI.
  • To discuss current management strategies and future directions in MCI research.

Main Methods:

  • Review of existing literature on MCI diagnosis and management.
  • Analysis of cognitive assessment tools and neuroimaging techniques (MRI, PET).

Related Experiment Videos

  • Evaluation of current and emerging therapeutic interventions.

    • Main Results:

    • MCI diagnosis requires comprehensive assessment of cognitive domains, particularly memory.
    • Neuroimaging aids in both diagnosis and prognosis of MCI.
    • While no definitive long-term treatments exist, symptomatic relief may be achieved with acetylcholinesterase inhibitors.

    Conclusions:

    • MCI is a clinically significant condition requiring thorough etiological assessment.
    • Effective management involves counseling and judicious use of available treatments.
    • Continued research is needed to develop disease-modifying therapies for MCI.